Squarepoint’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $897K | Buy |
+5,197
| New | +$897K | ﹤0.01% | 1589 |
|
|
2024
Q1 | – | Sell |
-5,881
| Closed | -$741K | – | 2429 |
|
|
2023
Q4 | $741K | Buy |
+5,881
| New | +$741K | ﹤0.01% | 1497 |
|
|
2023
Q3 | – | Sell |
-11,125
| Closed | -$993K | – | 2444 |
|
|
2023
Q2 | $993K | Buy |
+11,125
| New | +$993K | ﹤0.01% | 1259 |
|
|
2022
Q4 | – | Sell |
-17,329
| Closed | -$1.79M | – | 2254 |
|
|
2022
Q3 | $1.79M | Buy |
17,329
+13,609
| +366% | +$1.4M | 0.01% | 832 |
|
|
2022
Q2 | $346K | Buy |
+3,720
| New | +$346K | ﹤0.01% | 1519 |
|
|
2022
Q1 | – | Sell |
-1,826
| Closed | -$246K | – | 2215 |
|
|
2021
Q4 | $246K | Sell |
1,826
-2,082
| -53% | -$280K | ﹤0.01% | 1972 |
|
|
2021
Q3 | $623K | Sell |
3,908
-2,569
| -40% | -$410K | ﹤0.01% | 1276 |
|
|
2021
Q2 | $852K | Buy |
+6,477
| New | +$852K | ﹤0.01% | 1288 |
|
|
2020
Q4 | – | Sell |
-3,166
| Closed | -$489K | – | 2512 |
|
|
2020
Q3 | $489K | Buy |
+3,166
| New | +$489K | 0.01% | 1365 |
|
|
2020
Q2 | – | Sell |
-3,420
| Closed | -$385K | – | 2140 |
|
|
2020
Q1 | $385K | Buy |
+3,420
| New | +$385K | 0.01% | 1171 |
|
|
2019
Q2 | – | Sell |
-7,379
| Closed | -$869K | – | 2283 |
|
|
2019
Q1 | $869K | Buy |
7,379
+4,119
| +126% | +$485K | 0.01% | 1166 |
|
|
2018
Q4 | $204K | Buy |
+3,260
| New | +$204K | ﹤0.01% | 1662 |
|
|
2018
Q3 | – | Sell |
-4,300
| Closed | -$286K | – | 1967 |
|
|
2018
Q2 | $286K | Sell |
4,300
-1,200
| -22% | -$79.8K | ﹤0.01% | 1398 |
|
|
2018
Q1 | $360K | Buy |
+5,500
| New | +$360K | 0.01% | 1222 |
|